How Avenor helped a global healthcare company assess the pipeline for next-generation LAAC devices through strategic engagement with former cardiovascular device executives.
The client wanted to assess the pipeline for future left atrial appendage closure (LAAC) and atrial fibrillation devices, including next-generation implants and related support products such as delivery sheaths and ICE catheters. Their objective was to gain insights from former executives at leading global cardiovascular device companies, who could speak to strategy development, lifecycle management, and the evolving innovation landscape.
To address this request, Avenor conducted a custom recruitment effort focused exclusively on executives with direct experience in LAAC innovation and portfolio strategy. Unlike database-driven approaches, we identified and sourced former senior leaders from the specified companies, ensuring that each expert had hands-on responsibility for product development, commercialization, or strategic planning in this device category.
Before sharing any experts with the client, Avenor spent ~15 minutes on the phone with each candidate to validate their knowledge, confirm direct relevance, and capture preliminary perspectives on device innovation trends.
Through these engagements, the client gained targeted, actionable intelligence on the LAAC innovation landscape.
Submit your research brief and get matched with pre-vetted experts in 12-24 hours.